Patent ID: 8563555

Claim:
A pharmaceutical composition comprising crystalline form Y of posaconazole and optionally at least one pharmaceutically acceptable additive, wherein the crystalline form Y of posaconazole has at least one of an X-ray powder diffraction pattern comprising peaks at 2-theta angles of approximately 2.4°±0.2°, 9.5°±0.2°, 15.0°±0.2°, 17.7°±0.2°, and 23.7°±0.2° or an attenuated total reflectance infrared spectrum comprising absorption bands at wavenumbers of about 3566±2 cm −1 , 2881±2 cm −1 , 2822±2 cm −1 , 1690±2 cm −1 , 1508±2 cm −1 , 1473±2 cm −1 , 1226±2 cm −1 , 1040±2 cm −1 , 947±2 cm −1 , 849±2 cm −1 and 823 cm −1 ±2 cm −1 .